Literature DB >> 19457992

Modulation of human immunodeficiency virus type 1 protease autoprocessing by charge properties of surface residue 69.

Liangqun Huang1, Jane M Sayer, Marie Swinford, John M Louis, Chaoping Chen.   

Abstract

Mature, fully active human immunodeficiency virus protease (PR) is liberated from the Gag-Pol precursor via regulated autoprocessing. A chimeric protease precursor, glutathione S-transferase-transframe region (TFR)-PR-FLAG, also undergoes N-terminal autocatalytic maturation when it is expressed in Escherichia coli. Mutation of the surface residue H69 to glutamic acid, but not to several neutral or basic amino acids, impedes protease autoprocessing in bacteria and mammalian cells. Only a fraction of mature PR with an H69E mutation (PR(H69E)) folds into active enzymes, and it does so with an apparent Kd (dissociation constant) significantly higher than that of the wild-type protease, corroborating the marked retardation of the in vitro N-terminal autocatalytic processing of TFR-PR(H69E) and suggesting a folding defect in the precursor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457992      PMCID: PMC2708634          DOI: 10.1128/JVI.00473-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

Review 1.  HIV-1 protease: maturation, enzyme specificity, and drug resistance.

Authors:  J M Louis; I T Weber; J Tözsér; G M Clore; A M Gronenborn
Journal:  Adv Pharmacol       Date:  2000

Review 2.  HIV-1 protease: structure, dynamics, and inhibition.

Authors:  John M Louis; Rieko Ishima; Dennis A Torchia; Irene T Weber
Journal:  Adv Pharmacol       Date:  2007

3.  Effect of the active site D25N mutation on the structure, stability, and ligand binding of the mature HIV-1 protease.

Authors:  Jane M Sayer; Fengling Liu; Rieko Ishima; Irene T Weber; John M Louis
Journal:  J Biol Chem       Date:  2008-02-15       Impact factor: 5.157

4.  Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection.

Authors:  C Chen; F Li; R C Montelaro
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication.

Authors:  Feng Li; Chaoping Chen; Bridget A Puffer; Ronald C Montelaro
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Structural evidence for effectiveness of darunavir and two related antiviral inhibitors against HIV-2 protease.

Authors:  Andrey Y Kovalevsky; John M Louis; Annie Aniana; Arun K Ghosh; Irene T Weber
Journal:  J Mol Biol       Date:  2008-09-20       Impact factor: 5.469

7.  Visualizing transient events in amino-terminal autoprocessing of HIV-1 protease.

Authors:  Chun Tang; John M Louis; Annie Aniana; Jeong-Yong Suh; G Marius Clore
Journal:  Nature       Date:  2008-10-02       Impact factor: 49.962

8.  The structural stability of the HIV-1 protease.

Authors:  M J Todd; N Semo; E Freire
Journal:  J Mol Biol       Date:  1998-10-23       Impact factor: 5.469

9.  Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins.

Authors:  E Cherry; C Liang; L Rong; Y Quan; P Inouye; X Li; N Morin; M Kotler; M A Wainberg
Journal:  J Mol Biol       Date:  1998-11-20       Impact factor: 5.469

10.  Importance of protease cleavage sites within and flanking human immunodeficiency virus type 1 transframe protein p6* for spatiotemporal regulation of protease activation.

Authors:  Christine Ludwig; Andreas Leiherer; Ralf Wagner
Journal:  J Virol       Date:  2008-03-05       Impact factor: 5.103

View more
  10 in total

1.  Understanding HIV-1 protease autoprocessing for novel therapeutic development.

Authors:  Liangqun Huang; Chaoping Chen
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

2.  Cysteine 95 and other residues influence the regulatory effects of Histidine 69 mutations on Human Immunodeficiency Virus Type 1 protease autoprocessing.

Authors:  Liangqun Huang; Alyssa Hall; Chaoping Chen
Journal:  Retrovirology       Date:  2010-03-23       Impact factor: 4.602

3.  Autoprocessing of human immunodeficiency virus type 1 protease miniprecursor fusions in mammalian cells.

Authors:  Liangqun Huang; Chaoping Chen
Journal:  AIDS Res Ther       Date:  2010-07-28       Impact factor: 2.250

4.  Flexible catalytic site conformations implicated in modulation of HIV-1 protease autoprocessing reactions.

Authors:  Liangqun Huang; Yanfei Li; Chaoping Chen
Journal:  Retrovirology       Date:  2011-10-10       Impact factor: 4.602

5.  A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity.

Authors:  Christopher J Counts; P Shing Ho; Maureen J Donlin; John E Tavis; Chaoping Chen
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

6.  Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics.

Authors:  Johnson Agniswamy; John M Louis; Julien Roche; Robert W Harrison; Irene T Weber
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

7.  Construction of a molecular clone of ovine enzootic nasal tumor virus.

Authors:  Scott R Walsh; María Carla Rosales Gerpe; Sarah K Wootton
Journal:  Virol J       Date:  2016-12-30       Impact factor: 4.099

8.  Targeting HIV-1 Protease Autoprocessing for High-throughput Drug Discovery and Drug Resistance Assessment.

Authors:  Liangqun Huang; Linfeng Li; ChihFeng Tien; Daniel V LaBarbera; Chaoping Chen
Journal:  Sci Rep       Date:  2019-01-22       Impact factor: 4.379

9.  High-affinity RNA Aptamers Against the HIV-1 Protease Inhibit Both In Vitro Protease Activity and Late Events of Viral Replication.

Authors:  Sonald Duclair; Archana Gautam; Andrew Ellington; Vinayaka R Prasad
Journal:  Mol Ther Nucleic Acids       Date:  2015-02-17       Impact factor: 10.183

10.  Context-dependent autoprocessing of human immunodeficiency virus type 1 protease precursors.

Authors:  ChihFeng Tien; Liangqun Huang; Susan M Watanabe; Jordan T Speidel; Carol A Carter; Chaoping Chen
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.